A novel missense mutation in the glycogen branching enzyme gene in a child with myopathy and hepatopathy

Neuromuscul Disord. 1999 Oct;9(6-7):403-7. doi: 10.1016/s0960-8966(99)00040-1.

Abstract

We have identified a novel missense mutation in the gene for glycogen branching enzyme (GBE 1) in a 16-month-old infant with a combination of hepatic and muscular features, an atypical clinical presentation of glycogenosis type IV (GSD IV). The patient was heterozygous for a G-to-A substitution at codon 524 (R524Q), changing an encoded arginine (CGA) to glutamine (CAA), while the GBE1 gene on the other allele was not expressed. This case broadens the spectrum of mutations in patients with GSD IV and confirms the clinical and molecular heterogeneity of this disease.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1,4-alpha-Glucan Branching Enzyme / genetics*
  • Amino Acid Substitution
  • Arginine
  • Base Sequence
  • Cytoplasmic Granules / pathology
  • Cytoplasmic Granules / ultrastructure
  • Glutamine
  • Glycogen Storage Disease Type IV / enzymology
  • Glycogen Storage Disease Type IV / genetics
  • Heterozygote
  • Humans
  • Infant
  • Liver / pathology*
  • Liver / ultrastructure
  • Liver Diseases / enzymology
  • Liver Diseases / genetics*
  • Liver Diseases / pathology
  • Male
  • Muscle, Skeletal / pathology*
  • Muscle, Skeletal / ultrastructure
  • Muscular Diseases / enzymology
  • Muscular Diseases / genetics*
  • Muscular Diseases / pathology
  • Mutation, Missense*

Substances

  • Glutamine
  • Arginine
  • 1,4-alpha-Glucan Branching Enzyme